Non-Current Assets
AFS Securities
Moderna AFS Securities decreased by 3.6% to $2.25B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 6.9%, from $2.42B to $2.25B. Over 5 years (FY 2020 to FY 2025), AFS Securities shows an upward trend with a 29.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2017
Last reportedQ1 2026May 1, 2026
Parent metricTotal investment securities
How to read this metric
An increase reflects capital allocation toward investment portfolios, while a decrease may signal portfolio rebalancing or asset liquidation.
Detailed definition
Available-for-sale securities are debt or equity investments that are not classified as trading or held-to-maturity, and...
Peer comparison
Common in the investment portfolios of banks and insurance companies.
Metric ID:
fin_afs_securitiesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.21B | $6.44B | $6.84B | $9.17B | $10.16B | $8.66B | $8.32B | $7.44B | $6.11B | $5.27B | $4.68B | $3.64B | $2.33B | $2.34B | $2.49B | $2.42B | $2.37B | $2.14B | $2.34B | $2.25B |
| QoQ Change | — | +53.1% | +6.2% | +34.0% | +10.8% | -14.8% | -3.9% | -10.5% | -18.0% | -13.6% | -11.3% | -22.2% | -36.1% | +0.4% | +6.8% | -3.0% | -1.8% | -9.7% | +9.0% | -3.6% |
| YoY Change | — | — | — | — | +141.5% | +34.4% | +21.6% | -18.9% | -39.9% | -39.1% | -43.8% | -51.1% | -61.9% | -55.7% | -46.7% | -33.5% | +2.1% | -8.2% | -6.3% | -6.9% |
Range$2.14B – $10.16B
CAGR-12.3%
Avg YoY Growth-13.3%
Median YoY Growth-26.2%
AFS Securities at Other Companies
Frequently Asked Questions
- What is Moderna's afs securities?
- Moderna (MRNA) reported afs securities of $2.25B in Q1 2026.
- How has Moderna's afs securities changed year-over-year?
- Moderna's afs securities decreased by 6.9% year-over-year, from $2.42B to $2.25B.
- What is the long-term trend for Moderna's afs securities?
- Over 5 years (2020 to 2025), Moderna's afs securities has grown at a 29.6% compound annual growth rate (CAGR), from $639.00M to $2.34B.
- What does afs securities mean?
- Investments in securities that are held for potential sale and marked to fair market value.